Page 140 - Genomic Medicine in Emerging Economies

References 129

Sesarini, C.V., Costa, L., Granana, N., Coto, M.G., Pallia, R.C., Argibay, P.F., 2015. Association
between GABA(A) receptor subunit polymorphisms and autism spectrum disorder (ASD).
Psychiatry Res. 229 (1–2), 580–582. doi: 10.1016/j.psychres.2015.07.077.
Sesarini, C.V., Costa, L., Naymark, M., Granana, N., Cajal, A.R., Garcia Coto, M., Argibay, P.F., 2014.
Evidence for interaction between markers in GABA(A) receptor subunit genes in an Argentin-
ean autism spectrum disorder population. Autism Res. 7 (1), 162–166. doi: 10.1002/aur.1353.
Sharan, P., Gallo, C., Gureje, O., Lamberte, E., Mari, J.J., Mazzotti, G., World Health Organization-
Global Forum for Health Research – Mental Health Research Mapping Project, Group, 2009.
Mental health research priorities in low- and middle-income countries of Africa, Asia, Latin
America and the Caribbean. Br. J. Psychiatry 195 (4), 354–363. doi: 10.1192/bjpbp.108.050187.
Solís-ortiz, S., Perez-Luque, E., Morado-Crespo, L., Gutierrez-Munoz, M., 2010. Executive functions
and selective attention are favored in middle-aged healthy women carriers of the Val/Val geno-
type of the catechol-o-methyltransferase gene: a behavioral genetic study. Behav. Brain Funct.
6, 67. doi: 10.1186/1744-9081-6-67.
Sosa-Macias, M., Teran, E., Waters, W., Fors, M.M., Altamirano, C., Jung-Cook, H.A., Lerena, L.,
2016. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials,
pharmacovigilance and drug regulation in Latin America. Pharmacogenomics, 10.2217/pgs-
2016-0153.
Speck-Hernandez, C.A., Ojeda, D.A., Castro-Vega, L.J., Forero, D.A., 2015. Relative telomere length
is associated with a functional polymorphism in the monoamine oxidase A gene in a South
American sample. J. Genet. 94 (2), 305–308.
Stewart, S.E., Yu, D., Scharf, J.M., Neale, B.M., Fagerness, J.A., Mathews, C.A., Pauls, D.L., 2013.
Genome-wide association study of obsessive-compulsive disorder. Mol. Psychiatry 18 (7),
788–798. doi: 10.1038/mp.2012.85.
Suarez-Kurtz, G., 2004. Pharmacogenomics in admixed populations: the Brazilian pharmacoge-
netics/pharmacogenomics network--REFARGEN. Pharmacogenomics J. 4 (6), 347–348. doi:
10.1038/sj.tpj.6500287.
Suarez-Kurtz, G., Pena, S.D., 2006. Pharmacogenomics in the Americas: the impact of genetic
admixture. Curr. Drug Targets 7 (12), 1649–1658.
Sudmant, P.H., Rausch, T., Gardner, E.J., Handsaker, R.E., Abyzov, A., Huddleston, J., Korbel, J.O.,
2015. An integrated map of structural variation in 2,504 human genomes. Nature 526 (7571),
75–81. doi: 10.1038/nature15394.
Tovilla-Zarate, C.A., Vargas, I., Hernandez, S., Fresan, A., Aguilar, A., Escamilla, R., Camarena, B.,
2014. Association study between the MDR1 gene and clinical characteristics in schizophrenia.
Rev. Bras. Psiquiatr. 36 (3), 227–232.
Tovilla-Zarate, C., Medellin, B.C., Fresan, A., Lopez-Narvaez, L., Castro, T.B., Juarez Rojop, I., Nico-
lini, H., 2013. No association between catechol-o-methyltransferase Val108/158Met polymor-
phism and schizophrenia or its clinical symptomatology in a Mexican population. Mol. Biol.
Rep. 40 (2), 2053–2058. doi: 10.1007/s11033-012-2264-x.
Tovo-Rodrigues, L., Rohde, L.A., Menezes, A.M., Polanczyk, G.V., Kieling, C., Genro, J.P., Hutz,
M.H., 2013. DRD4 rare variants in attention-deficit/hyperactivity disorder (ADHD):
further evidence from a birth cohort study. PLoS One 8 (12), e85164. doi: 10.1371/journal.
pone.0085164.
Tovo-Rodrigues, L., Rohde, L.A., Roman, T., Schmitz, M., Polanczyk, G., Zeni, C., Hutz, M.H., 2012.
Is there a role for rare variants in DRD4 gene in the susceptibility for ADHD? Searching for
an effect of allelic heterogeneity. Mol. Psychiatry 17 (5), 520–526. doi: 10.1038/mp.2011.12.
Urraca, N., Camarena, B., Aguilar, A., Fresan, A., Apiquian, R., Orozco, L., Nicolini, H., 2011.
Association study of DRD3 gene in schizophrenia in Mexican sib-pairs. Psychiatry Res. 190
(2–3), 367–368. doi: 10.1016/j.psychres.2011.06.009.